Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies

Patients with COVID-19 and underlying hematological malignancy seem to have a higher mortality rate compared with those patients without malignancy, however, the extent of such excess risk is unclear. We performed a systematic review of literature and a pooled analysis to provide precise estimates o...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Kamal S., Tagliamento, Marco, Lambertini, Matteo, McNally, Richard, Kelly, Adrianne, Romano, Marco, Chico, Isagani, Jenson, Taylor, Anderson, Steven M, Curigliano, Giuseppe, de Azambuja, Evandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
901.Health Services Research-Non-Malignant Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330307/
http://dx.doi.org/10.1182/blood-2020-141749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330307/
http://dx.doi.org/10.1182/blood-2020-141749

Ejemplares similares